Immunosuppressive agents used to treat inflammatory bowel disease can increase the risk for infections, several of which are preventable through vaccination. The recent study aimed to describe vaccine utilization by immunosuppression status, examine reasons for vaccine refusal, and identify characteristics associated with lack of influenza vaccination in IBD patients. Vaccine utilization remains sub-optimal in IBD patients. Educational interventions may increase vaccination rates by clarifying misconceptions. GIs can play a more active role in health care maintenance in IBD patients by counseling patients on which vaccines to receive or avoid.